These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 4124889

  • 21. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D, Bougherbal R.
    Nouv Presse Med; 1975 Feb 01; 4(5):351-2. PubMed ID: 1093125
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718).
    Stroobandt R, Bennett PB, Hondeghem LM, Kesteloot H.
    Eur J Clin Pharmacol; 1987 Feb 01; 32(5):449-56. PubMed ID: 2441995
    [Abstract] [Full Text] [Related]

  • 23. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].
    Hagemeijer F, Janse C, Hugenholtz PG.
    Acta Cardiol; 1974 Feb 01; Suppl 18():409-21. PubMed ID: 4138502
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A, Bonatti V, Finardi A, Favaro L, Botti G.
    G Ital Cardiol; 1981 Feb 01; 11(4):468-76. PubMed ID: 6169578
    [Abstract] [Full Text] [Related]

  • 25. Tiapamil in the treatment of lidocaine-resistant ventricular arrhythmias complicating acute myocardial infarction.
    Lessem J.
    Cardiology; 1982 Feb 01; 69 Suppl():199-208. PubMed ID: 7151080
    [Abstract] [Full Text] [Related]

  • 26. [Causes and treatment of ventricular arrhythmias].
    Kappenberger L.
    Schweiz Med Wochenschr; 1990 Jun 23; 120(25):941-5. PubMed ID: 1695020
    [Abstract] [Full Text] [Related]

  • 27. [Effect of aprindine on ventricular arrhthmias].
    Domínguez JF, Martín Sánchez JC, Ciscar A, Hidalgo M, Petit Guinovart M, Ballesta Barcons F.
    Rev Esp Cardiol; 1975 Jun 23; 38(2):145-52. PubMed ID: 49071
    [No Abstract] [Full Text] [Related]

  • 28. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F, Cremonesi A, Pagliarani PL, Guelfi P, Bugiardini R, Lasagna I, Ghinelli M, Luciani G.
    Minerva Cardioangiol; 1981 Nov 23; 29(11):655-60. PubMed ID: 6173818
    [No Abstract] [Full Text] [Related]

  • 29. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M, Noll B, Krappe J.
    Internist (Berl); 1985 Dec 23; 26(12):741-9. PubMed ID: 2417980
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS, Oversohl K, Seidl KF.
    Med Klin; 1974 May 03; 69(18):814-7. PubMed ID: 4134646
    [No Abstract] [Full Text] [Related]

  • 31. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia.
    Horowitz LN, Greenspan AM, Spielman SR, Frye SJ, Yacone LA, Lowenthal DT.
    Clin Pharmacol Ther; 1985 Jun 03; 37(6):644-8. PubMed ID: 2408808
    [Abstract] [Full Text] [Related]

  • 32. Clinical pharmacological studies of Kö 1173--a new antiarrhythmic agent.
    Clark RA, Julian DG, Nimmo J, Prescott LF, Talbot R.
    Br J Pharmacol; 1973 Mar 03; 47(3):622P-623P. PubMed ID: 4730842
    [No Abstract] [Full Text] [Related]

  • 33. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ, Roden D, Primm RK, Oates JA, Woosley RL.
    Circulation; 1983 May 03; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Mexiletine.
    Talbot RG.
    Am Heart J; 1975 Apr 03; 89(4):537-8. PubMed ID: 1114985
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias.
    Allen JD, Kelly JG, James RG, Shanks RG, Zaidi SA.
    Postgrad Med J; 1977 Apr 03; 53 Suppl 1():35-47. PubMed ID: 876952
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD, Ekue JM, Shanks RG, Zaidi SA.
    Br J Pharmacol; 1972 Aug 03; 45(4):561-73. PubMed ID: 5085230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.